Notice of Compliance information

From Health Canada

New search
Notice of Compliance date:
2011-12-08
Manufacturer:
GENZYME CANADA INC
Product type:
Prescription Pharmaceutical
NOC with conditions:
No
Submission type:
New Drug Submission (NDS)
Submission class:
New Active Substance (NAS)
Therapeutic class:
Hematopoitic Agent

Brand 1 of 1 :

MOZOBIL

Product 1 of 1 :

Drug identification number:  02377225
Dosage form(s): Solution
Route(s) of administration: Subcutaneous
Medicinal ingredient(s):
This table displays medicinal ingredients information.
Ingredient Strength
PLERIXAFOR 20 MG/ML
New search
Date modified: